Literature Review of Cardiovascular Pathology in Coronavirus Infection

  • Yusupova Mamlakat Fergana Medical Institute of Public Health Department of Internal Medicine №1
Keywords: Coronavirus infection, COVID-19, cardiovascular system, myocarditis, arrhythmia, cardiogenic syndrome, stroke


In the context of globalization, a new type of coronavirus infection has led the entire healthcare system of all countries to a high alert mode, which made it possible to comprehensively study this disease and its complications. This article summarizes changes in the cardiovascular system based on the publications of European and Chinese scientists.


1. Zheng YY, Ma YT, Zhang JY, XieX. COVID-19 and the cardiovascular system. Nat Rev Cardiol . 2020;17: 259–260.
2. Wu Z., McGoogan JM Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA. 2020; 323:1239 -1242.
3. Zheng YY, Ma YT, Zhang JY, XieX. COVID-19 and the cardiovascular system. Nat Rev Cardiol . 2020;17: 259–260.
4. DrigginE., MadhavanMV, BikdeliB. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am CallCardiol . 2020; 75:2352 -2371.
5. Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395: 497–506.
6. Tam CCF, Cheung K.-S., Lam S. Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes. 2020; 13:e 006631.
7. Li Q., Guan X., Wu P. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N EnglJ Med. 2020;382: 1199–1207.
8. Kochi AN, Tagliari AP, Forleo GB, Fassini GM, TondoC. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol . 2020;31: 1003–1008.
9. Shao F., Xu S., Ma X. In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China. Resuscitation. 2020;151: 18–23.
10. BaldiE., SechiGM, Mare C. Out-of-hospital cardiac arrest during the Covid-19 outbreak in Italy. N EnglJ Med. 2020
11. LazzeriniPE, BoutjdirM., CapecchiPL COVID-19, arrhythmic risk and inflammation: mind the gap! [ epubahead of print] Circulation. 2020 doi : 10.1161/CIRCULATIONAHA.120.047293.
12. Sapp JL, AlqarawiW., MacIntyreCJ Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: a statement from the Canadian Heart Rhythm Society. Can J Cardiol . 2020;36: 948–951.
13. Zhou F., Yu T., Du R. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395: 1054-1062.
14. StefaniniGG, MontorfanoM., TrabattoniD. ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes. circulation. 2020;141:2113 -2116.
15. Bangalore S., Sharma A., SlotwinerA. ST-segment elevation in patients with Covid-19: a case series. N EnglJ Med. 2020
16. Chen T., Wu D., Chen H. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: a retrospective study. BMJ. 2020;26 368:m1091.
17. MacLarenG., Fisher D., Brodie D. Preparing for the most critically ill patients with COVID-18. JAMA. 2020;323:1245.
18. Zeng Y., CaiZ., XianyuY., Yang BX, Song T., Yan Q. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series. Critcare. 2020;24:148 .
19. KlokFA, KruipMJHA, van der Meer NJM Incidence of thrombotic complications in critically ill ICU patients with COVID-19. ThrombRes. 2020;191: 145–147.
20. MehraMR, RuschitzkaF. COVID-19 illness and heart failure. JACC Heart Fail. 2020;8: 512–514.
21. Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thrombhaemost. 2020;18: 844–847.
22. KlokFA, KruipMJHA, van der Meer NJM Incidence of thrombotic complications in critically ill ICU patients with COVID-19. ThrombRes. 2020; 191: 145–147.
23. PoissyJ., GoutayJ., Caplan M. Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence [epubahead of print] Circulation. 2020 doi: 10.1161/CIRCULATIONAHA.120.047430.
24. BikdeliB., MadhavanMV, Jimenez D. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Call Cardiol . 2020;75: 2950–2973.
25. Mao L., Jin H., Wang M. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77: 683–690.
26. BeyroutiR., Adams ME, Benjamin L. Characteristics of is chaemic stroke associated with COVID-19 [ epubahead of print] J Neurol Neurosurgical Psychiatry. 2020 doi : 10.1136/jnnp-2020-323586.
27. Oxley TJ, MoccoJ., MajidiS. Large-vessel stroke as a presenting feature of Covid-19 in the young. N EnglJ Med. 2020; 382:e 60.
28. Rodríguez-Leor O., Cid- ÁlvarezB., Ojeda S. Impactode la pandemiade COVID-19 sobrela actividad assistenc ialencardiology in terventionistaen España . REC IntervCardiol . 2020;2: 82–89.
29. MoroniF., GramegnaM., AjelloS. Collateral damage: medical care avoidance behavior among patients with myocardial infarction during the COVID-19 pandemic [ Epubahead of print] JACC Case Reports. 2020 doi : 10.1016/j.jaccas.2020.04.010.
30. Kim AHJ, Sparks JA, LiewJW A Rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxyl chloroquine for COVID-19. Ann Intern Med. 2020; 172: 819–821.
31. Sanders JM, MonogueML, JodlowskiTZ, CutrellJB Pharmacologic treatments for coronavirus disease 2019 (COVID-19) [Epubahead of print] JAMA. 2020 doi : 10.1001/jama.2020.6019.
How to Cite
Mamlakat, Y. (2022). Literature Review of Cardiovascular Pathology in Coronavirus Infection. Central Asian Journal of Medical and Natural Science, 3(2), 396-400.